0
Upcoming Allied Market Research
2023
Cardiac Arrhythmia Monitoring Devices Market

Cardiac Arrhythmia Monitoring Devices Market

Report Code: A11909
Nov 2023 | Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Cardiac Arrhythmia Monitoring Devices Market

Request Now !

A range of treatments have been developed for the management of cardiac arrhythmias. These include antiarrhythmic drugs, artificial pacemakers, implanted cardiac defibrillators and ablation of damaged or malfunctioning cardiac tissue. However, to allow a physician to choose the most suitable course of treatment for a patient, it is important that the correct diagnosis be made in an appropriate period of time. Cardiac monitors can provide the physician with electrocardiogram (ECG) data that can either confirm or rule out the presence of an arrhythmia. The symptoms described by the patient should allow the physician to decide which method of cardiac monitoring is most suitable in order to maximise the outcome of a successful diagnosis. Several types of device are used to remotely assess cardiac rhythm abnormalities in ambulatory patients. The largest category of devices includes patient- and event-activated intermittent recorders. These devices may be pre-symptom continuous-loop or post-symptom recorders, and can be worn externally or implanted into the body. Continuous real time remote cardiac monitoring is the newest category with four devices commercially available. These devices can transmit ECG data to a central, attended monitoring station.

Covid-19 Scenario analysis:

At the early phase of COVID-19 pandemic, there was no availability of specific diagnostic tests to detect the disease in patients. Alternative diagnostic tests were used initially but were not much effective. This unavailability of specific COVID-19 diagnostic tests presented lucrative opportunities for diagnostic manufacturers to introduce their COVID-19 diagnostic kits. Many leading players as well as some start-ups from various countries utilized this opportunity and introduced COVID-19 diagnostics kits into local as well as global market. These players achieved edge over other diagnostics players capitalizing the opportunity from demand for COVID-19 diagnostic tests, which, in turn, helps them in maintaining their revenues in such a crisis.

Owing to such factors, COVID 19 is expected to have a significant impact on the cardiac arrhythmia monitoring devices market.

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact analysis:

Drivers:

Technological advancements and Increased number of cardiac patients:

One of the significant factors in this context has been the rise in the rate of occurrence of arrhythmias and the associated mortality. Such an increase in the mortality rate associated with arrhythmias is a significant factor that has boosted the industry. Increased cases of patients with cardiovascular diseases, the market is anticipated to witness the lucrative growth over the coming years. Growing technological advancements and innovations are further expected to boost the growth of the market. For instance, in 2016, researchers at the Polytechnic University of Valencia and Hospital Gregorio Maranon in Madrid developed a system for diagnosing and treating atrial fibrillation in real-time that has reduced the cost & duration and has further increased the effectiveness of surgical intervention. Such innovations, leading to emergence of heart rhythm monitors will spur the cardiac arrhythmia monitoring devices industry growth.

Increasing demand for home monitoring devices booming:

Real-time cardiac disease monitoring has made revolutionary changes in patient care across homecare settings, clinics, outpatient centres and outdoor care models. The integration of real-time patient monitoring platforms with diagnostic equipment has helped physicians to take more precise treatment decisions. This has led to an increase in the efficacy of overall treatment and also reduced the patient morbidity caused due to late diagnostics.

The integrative approach between computer science, communication technology, and medicine has enabled the service provider to cater to patient need efficiently. The emergence of telemedicine and popularisation smartphone technology has changed the landscape of cardiac monitoring. Furthermore, the companies operating in the market are competing on the basis of more advanced and connected cardiac arrhythmia monitoring devices which is anticipated to fuel the market growth in the near future.

Restraints:

Patient-activated devices will only record what the patient perceives to be symptomatic events. Patients may also have difficulty activating the recorder while symptoms are being experienced, which may lead to the event being partially recorded. These limitations will not apply to automatic event-activated recorders as they can record both symptomatic and asymptomatic arrhythmias. However, depending on the programming used, the device may activate unnecessarily (i.e. false event) or may not record during some symptomatic events.

This would be a result of pre-programmed rhythm specification that causes the device to activate and record. Limited device memory could also lead to a false event erasing a previously recorded true event. Less memory will also mean that more frequent downloads or transmissions will be required for multiple recorded events. Post-symptom looping devices are limited in that the arrhythmia may have ended before the recorder is activated post-event.

Regional analysis:

Countries in the Asia pacific region, such as China and India, are the hotspots for investment opportunities because of higher growth rate of diagnosis, treatment and research activities, quality improvisations, increasing number of partnerships and healthcare modernization. To increase the revenue share, EGC monitoring device manufacturing companies are focusing on the development of advanced ECG monitoring devices such as, cardiac telemetry monitors and implantable cardiac monitors with advanced facilities, that will indirectly pump the demand of cardiac arrhythmia monitoring devices and also boost the services and software market over the forecast period.

Market analysis:

Increasing demand for high end, advanced ECG monitoring devices from end users, such as hospitals, ambulatory surgical centres, diagnostics centres, homecare settings and emergency medical services for better output and performance, will generate opportunities for launching of novel ECG monitoring devices in the market in the long run. Use of ECG monitoring devices and services has skyrocketed over the past decade. ECG has penetrated into different departments owing to its extensive use in mobile cardiac outpatient telemetry and currently in data management for electronic medical records (EMR). The growing number of life threatening cardiac diseases has led to a threefold increase in the demand for ECG monitoring devices and services in hospitals and diagnostics laboratories with the necessary and advanced software services. The aforesaid factors will increase the demand for ECG monitoring devices, data management and services in large integrated healthcare systems.

Key benefits of the report:

  • This study presents the analytical depiction of the global cardiac arrhythmia monitoring devices industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global cardiac arrhythmia monitoring devices market share.
  • The current market is quantitatively analyzed to highlight the global cardiac arrhythmia monitoring devices market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed global cardiac arrhythmia monitoring devices market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Cardiac arrhythmia monitoring devices Market research report:

  • What are the leading market players active in the Cardiac arrhythmia monitoring devices market?
  • What the current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Cardiac Arrhythmia Monitoring Devices Market Report Highlights

Aspects Details
By Type
  • Standards in Ambulatory Cardiac Monitoring
  • Patient- and Event-activated Intermittent Recorders
  • External Loop Recorders Pre-symptom Memory Loop Cardiac Event Recorders
  • Post-symptom Event Recorders
  • Continuous Real time Attended Remote Cardiac Monitors
  • Mobile Cardiac Outpatient Telemetry System
  • Vital Signs Transmitter (Bio watch Medical)
By Application
  • Atrial Fibrillation
  • Bradycardia
  • Conduction Disorders
  • Premature Contraction
  • Tachycardia
  • Ventricular Fibrillation
  • Others
By End Users
  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Homecare Settings
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Rest of LAMEA)
Key Market Players AliveCor, General Electric, Fukuda Denshi, Nihon Kohden, Medronic, Biotronik, Koninklijke Philips, Biotelemetry, NUUBO, Abbott, Hill-Rom, OSI Systems
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, BY TYPE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Type

    • 4.2. Standards In Ambulatory Cardiac Monitoring

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Patient- And Event-activated Intermittent Recorders

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. External Loop Recorders Pre-symptom Memory Loop Cardiac Event Recorders

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Post-symptom Event Recorders

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

    • 4.6. Continuous Real Time Attended Remote Cardiac Monitors

      • 4.6.1. Key Market Trends, Growth Factors and Opportunities

      • 4.6.2. Market Size and Forecast, By Region

      • 4.6.3. Market Share Analysis, By Country

    • 4.7. Mobile Cardiac Outpatient Telemetry System

      • 4.7.1. Key Market Trends, Growth Factors and Opportunities

      • 4.7.2. Market Size and Forecast, By Region

      • 4.7.3. Market Share Analysis, By Country

    • 4.8. Vital Signs Transmitter (Bio Watch Medical)

      • 4.8.1. Key Market Trends, Growth Factors and Opportunities

      • 4.8.2. Market Size and Forecast, By Region

      • 4.8.3. Market Share Analysis, By Country

  • CHAPTER 5: CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Atrial Fibrillation

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Bradycardia

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Conduction Disorders

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Premature Contraction

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

    • 5.6. Tachycardia

      • 5.6.1. Key Market Trends, Growth Factors and Opportunities

      • 5.6.2. Market Size and Forecast, By Region

      • 5.6.3. Market Share Analysis, By Country

    • 5.7. Ventricular Fibrillation

      • 5.7.1. Key Market Trends, Growth Factors and Opportunities

      • 5.7.2. Market Size and Forecast, By Region

      • 5.7.3. Market Share Analysis, By Country

    • 5.8. Others

      • 5.8.1. Key Market Trends, Growth Factors and Opportunities

      • 5.8.2. Market Size and Forecast, By Region

      • 5.8.3. Market Share Analysis, By Country

  • CHAPTER 6: CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, BY END USERS

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End Users

    • 6.2. Hospitals

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Ambulatory Surgical Centers

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Diagnostic Centers

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Homecare Settings

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Others

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

  • CHAPTER 7: CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Type

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End Users

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Cardiac Arrhythmia Monitoring Devices Market

        • 7.2.6.1. Market Size and Forecast, By Type
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End Users
      • 7.2.7. Canada Cardiac Arrhythmia Monitoring Devices Market

        • 7.2.7.1. Market Size and Forecast, By Type
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End Users
      • 7.2.8. Mexico Cardiac Arrhythmia Monitoring Devices Market

        • 7.2.8.1. Market Size and Forecast, By Type
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End Users
    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Type

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End Users

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Cardiac Arrhythmia Monitoring Devices Market

        • 7.3.6.1. Market Size and Forecast, By Type
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End Users
      • 7.3.7. Germany Cardiac Arrhythmia Monitoring Devices Market

        • 7.3.7.1. Market Size and Forecast, By Type
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End Users
      • 7.3.8. Italy Cardiac Arrhythmia Monitoring Devices Market

        • 7.3.8.1. Market Size and Forecast, By Type
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End Users
      • 7.3.9. Spain Cardiac Arrhythmia Monitoring Devices Market

        • 7.3.9.1. Market Size and Forecast, By Type
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End Users
      • 7.3.10. UK Cardiac Arrhythmia Monitoring Devices Market

        • 7.3.10.1. Market Size and Forecast, By Type
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End Users
      • 7.3.11. Russia Cardiac Arrhythmia Monitoring Devices Market

        • 7.3.11.1. Market Size and Forecast, By Type
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End Users
      • 7.3.12. Rest Of Europe Cardiac Arrhythmia Monitoring Devices Market

        • 7.3.12.1. Market Size and Forecast, By Type
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End Users
    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Type

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End Users

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Cardiac Arrhythmia Monitoring Devices Market

        • 7.4.6.1. Market Size and Forecast, By Type
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End Users
      • 7.4.7. Japan Cardiac Arrhythmia Monitoring Devices Market

        • 7.4.7.1. Market Size and Forecast, By Type
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End Users
      • 7.4.8. India Cardiac Arrhythmia Monitoring Devices Market

        • 7.4.8.1. Market Size and Forecast, By Type
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End Users
      • 7.4.9. South Korea Cardiac Arrhythmia Monitoring Devices Market

        • 7.4.9.1. Market Size and Forecast, By Type
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End Users
      • 7.4.10. Australia Cardiac Arrhythmia Monitoring Devices Market

        • 7.4.10.1. Market Size and Forecast, By Type
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End Users
      • 7.4.11. Thailand Cardiac Arrhythmia Monitoring Devices Market

        • 7.4.11.1. Market Size and Forecast, By Type
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End Users
      • 7.4.12. Malaysia Cardiac Arrhythmia Monitoring Devices Market

        • 7.4.12.1. Market Size and Forecast, By Type
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End Users
      • 7.4.13. Indonesia Cardiac Arrhythmia Monitoring Devices Market

        • 7.4.13.1. Market Size and Forecast, By Type
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End Users
      • 7.4.14. Rest of Asia Pacific Cardiac Arrhythmia Monitoring Devices Market

        • 7.4.14.1. Market Size and Forecast, By Type
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End Users
    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Type

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End Users

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Cardiac Arrhythmia Monitoring Devices Market

        • 7.5.6.1. Market Size and Forecast, By Type
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End Users
      • 7.5.7. South Africa Cardiac Arrhythmia Monitoring Devices Market

        • 7.5.7.1. Market Size and Forecast, By Type
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End Users
      • 7.5.8. Saudi Arabia Cardiac Arrhythmia Monitoring Devices Market

        • 7.5.8.1. Market Size and Forecast, By Type
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End Users
      • 7.5.9. UAE Cardiac Arrhythmia Monitoring Devices Market

        • 7.5.9.1. Market Size and Forecast, By Type
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End Users
      • 7.5.10. Argentina Cardiac Arrhythmia Monitoring Devices Market

        • 7.5.10.1. Market Size and Forecast, By Type
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End Users
      • 7.5.11. Rest of LAMEA Cardiac Arrhythmia Monitoring Devices Market

        • 7.5.11.1. Market Size and Forecast, By Type
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End Users
  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. NUUBO

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Koninklijke Philips

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. General Electric

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Hill-Rom

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. OSI Systems

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Nihon Kohden

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Fukuda Denshi

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Biotelemetry

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. AliveCor

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Biotronik

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

    • 9.11. Medronic

      • 9.11.1. Company Overview

      • 9.11.2. Key Executives

      • 9.11.3. Company Snapshot

      • 9.11.4. Operating Business Segments

      • 9.11.5. Product Portfolio

      • 9.11.6. Business Performance

      • 9.11.7. Key Strategic Moves and Developments

    • 9.12. Abbott

      • 9.12.1. Company Overview

      • 9.12.2. Key Executives

      • 9.12.3. Company Snapshot

      • 9.12.4. Operating Business Segments

      • 9.12.5. Product Portfolio

      • 9.12.6. Business Performance

      • 9.12.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR STANDARDS IN AMBULATORY CARDIAC MONITORING, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR PATIENT- AND EVENT-ACTIVATED INTERMITTENT RECORDERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR EXTERNAL LOOP RECORDERS PRE-SYMPTOM MEMORY LOOP CARDIAC EVENT RECORDERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR POST-SYMPTOM EVENT RECORDERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR CONTINUOUS REAL TIME ATTENDED REMOTE CARDIAC MONITORS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR MOBILE CARDIAC OUTPATIENT TELEMETRY SYSTEM, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR VITAL SIGNS TRANSMITTER (BIO WATCH MEDICAL), BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR ATRIAL FIBRILLATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR BRADYCARDIA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR CONDUCTION DISORDERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR PREMATURE CONTRACTION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR TACHYCARDIA, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR VENTRICULAR FIBRILLATION, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR DIAGNOSTIC CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR HOMECARE SETTINGS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 23. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 26. NORTH AMERICA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 27. NORTH AMERICA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 28. U.S. CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 29. U.S. CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 30. U.S. CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 31. CANADA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 32. CANADA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. CANADA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 36. MEXICO CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 37. EUROPE CARDIAC ARRHYTHMIA MONITORING DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 41. FRANCE CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 42. FRANCE CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 43. FRANCE CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 44. GERMANY CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 45. GERMANY CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. GERMANY CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 47. ITALY CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 48. ITALY CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 49. ITALY CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 50. SPAIN CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 51. SPAIN CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 52. SPAIN CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 53. UK CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 54. UK CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 55. UK CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 56. RUSSIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 57. RUSSIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. RUSSIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 59. REST OF EUROPE CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 60. REST OF EUROPE CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 61. REST OF EUROPE CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 62. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 63. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 64. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 65. ASIA-PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 66. CHINA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 67. CHINA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 68. CHINA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 69. JAPAN CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 70. JAPAN CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 71. JAPAN CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 72. INDIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 73. INDIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 74. INDIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 75. SOUTH KOREA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 76. SOUTH KOREA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 77. SOUTH KOREA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 78. AUSTRALIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 79. AUSTRALIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 80. AUSTRALIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 81. THAILAND CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 82. THAILAND CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. THAILAND CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 84. MALAYSIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 85. MALAYSIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 86. MALAYSIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 87. INDONESIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 88. INDONESIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 89. INDONESIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 90. REST OF ASIA PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 91. REST OF ASIA PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 92. REST OF ASIA PACIFIC CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 93. LAMEA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 94. LAMEA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 95. LAMEA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 96. LAMEA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 97. BRAZIL CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 98. BRAZIL CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 99. BRAZIL CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 100. SOUTH AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 101. SOUTH AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 102. SOUTH AFRICA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 103. SAUDI ARABIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 104. SAUDI ARABIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 105. SAUDI ARABIA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 106. UAE CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 107. UAE CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 108. UAE CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 109. ARGENTINA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 110. ARGENTINA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 111. ARGENTINA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 112. REST OF LAMEA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 113. REST OF LAMEA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 114. REST OF LAMEA CARDIAC ARRHYTHMIA MONITORING DEVICES, BY END USERS, 2022-2032 ($MILLION)
  • TABLE 115. NUUBO: KEY EXECUTIVES
  • TABLE 116. NUUBO: COMPANY SNAPSHOT
  • TABLE 117. NUUBO: OPERATING SEGMENTS
  • TABLE 118. NUUBO: PRODUCT PORTFOLIO
  • TABLE 119. NUUBO: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 120. KONINKLIJKE PHILIPS: KEY EXECUTIVES
  • TABLE 121. KONINKLIJKE PHILIPS: COMPANY SNAPSHOT
  • TABLE 122. KONINKLIJKE PHILIPS: OPERATING SEGMENTS
  • TABLE 123. KONINKLIJKE PHILIPS: PRODUCT PORTFOLIO
  • TABLE 124. KONINKLIJKE PHILIPS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 125. GENERAL ELECTRIC: KEY EXECUTIVES
  • TABLE 126. GENERAL ELECTRIC: COMPANY SNAPSHOT
  • TABLE 127. GENERAL ELECTRIC: OPERATING SEGMENTS
  • TABLE 128. GENERAL ELECTRIC: PRODUCT PORTFOLIO
  • TABLE 129. GENERAL ELECTRIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 130. HILL-ROM: KEY EXECUTIVES
  • TABLE 131. HILL-ROM: COMPANY SNAPSHOT
  • TABLE 132. HILL-ROM: OPERATING SEGMENTS
  • TABLE 133. HILL-ROM: PRODUCT PORTFOLIO
  • TABLE 134. HILL-ROM: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 135. OSI SYSTEMS: KEY EXECUTIVES
  • TABLE 136. OSI SYSTEMS: COMPANY SNAPSHOT
  • TABLE 137. OSI SYSTEMS: OPERATING SEGMENTS
  • TABLE 138. OSI SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 139. OSI SYSTEMS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 140. NIHON KOHDEN: KEY EXECUTIVES
  • TABLE 141. NIHON KOHDEN: COMPANY SNAPSHOT
  • TABLE 142. NIHON KOHDEN: OPERATING SEGMENTS
  • TABLE 143. NIHON KOHDEN: PRODUCT PORTFOLIO
  • TABLE 144. NIHON KOHDEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 145. FUKUDA DENSHI: KEY EXECUTIVES
  • TABLE 146. FUKUDA DENSHI: COMPANY SNAPSHOT
  • TABLE 147. FUKUDA DENSHI: OPERATING SEGMENTS
  • TABLE 148. FUKUDA DENSHI: PRODUCT PORTFOLIO
  • TABLE 149. FUKUDA DENSHI: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 150. BIOTELEMETRY: KEY EXECUTIVES
  • TABLE 151. BIOTELEMETRY: COMPANY SNAPSHOT
  • TABLE 152. BIOTELEMETRY: OPERATING SEGMENTS
  • TABLE 153. BIOTELEMETRY: PRODUCT PORTFOLIO
  • TABLE 154. BIOTELEMETRY: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 155. ALIVECOR: KEY EXECUTIVES
  • TABLE 156. ALIVECOR: COMPANY SNAPSHOT
  • TABLE 157. ALIVECOR: OPERATING SEGMENTS
  • TABLE 158. ALIVECOR: PRODUCT PORTFOLIO
  • TABLE 159. ALIVECOR: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 160. BIOTRONIK: KEY EXECUTIVES
  • TABLE 161. BIOTRONIK: COMPANY SNAPSHOT
  • TABLE 162. BIOTRONIK: OPERATING SEGMENTS
  • TABLE 163. BIOTRONIK: PRODUCT PORTFOLIO
  • TABLE 164. BIOTRONIK: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 165. MEDRONIC: KEY EXECUTIVES
  • TABLE 166. MEDRONIC: COMPANY SNAPSHOT
  • TABLE 167. MEDRONIC: OPERATING SEGMENTS
  • TABLE 168. MEDRONIC: PRODUCT PORTFOLIO
  • TABLE 169. MEDRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 170. ABBOTT: KEY EXECUTIVES
  • TABLE 171. ABBOTT: COMPANY SNAPSHOT
  • TABLE 172. ABBOTT: OPERATING SEGMENTS
  • TABLE 173. ABBOTT: PRODUCT PORTFOLIO
  • TABLE 174. ABBOTT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET
  • FIGURE 3. SEGMENTATION CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALCARDIAC ARRHYTHMIA MONITORING DEVICES MARKET
  • FIGURE 11. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SEGMENTATION, BY BY TYPE
  • FIGURE 12. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR STANDARDS IN AMBULATORY CARDIAC MONITORING, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR PATIENT- AND EVENT-ACTIVATED INTERMITTENT RECORDERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR EXTERNAL LOOP RECORDERS PRE-SYMPTOM MEMORY LOOP CARDIAC EVENT RECORDERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR POST-SYMPTOM EVENT RECORDERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR CONTINUOUS REAL TIME ATTENDED REMOTE CARDIAC MONITORS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR MOBILE CARDIAC OUTPATIENT TELEMETRY SYSTEM, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR VITAL SIGNS TRANSMITTER (BIO WATCH MEDICAL), BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 20. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR ATRIAL FIBRILLATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 21. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR BRADYCARDIA, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR CONDUCTION DISORDERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR PREMATURE CONTRACTION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR TACHYCARDIA, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR VENTRICULAR FIBRILLATION, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 27. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET SEGMENTATION, BY BY END USERS
  • FIGURE 28. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR DIAGNOSTIC CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 31. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR HOMECARE SETTINGS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 32. CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 33. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 34. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 35. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 36. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 37. COMPETITIVE DASHBOARD
  • FIGURE 38. COMPETITIVE HEATMAP: CARDIAC ARRHYTHMIA MONITORING DEVICES MARKET
  • FIGURE 39. Top player positioning, 2022
  • FIGURE 40. NUUBO: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. NUUBO: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. NUUBO: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. KONINKLIJKE PHILIPS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. KONINKLIJKE PHILIPS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. KONINKLIJKE PHILIPS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. GENERAL ELECTRIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. GENERAL ELECTRIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. GENERAL ELECTRIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. HILL-ROM: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. HILL-ROM: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. HILL-ROM: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. OSI SYSTEMS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. OSI SYSTEMS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. OSI SYSTEMS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. NIHON KOHDEN: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. NIHON KOHDEN: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. NIHON KOHDEN: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 58. FUKUDA DENSHI: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. FUKUDA DENSHI: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 60. FUKUDA DENSHI: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 61. BIOTELEMETRY: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 62. BIOTELEMETRY: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 63. BIOTELEMETRY: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 64. ALIVECOR: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 65. ALIVECOR: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 66. ALIVECOR: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 67. BIOTRONIK: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 68. BIOTRONIK: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 69. BIOTRONIK: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 70. MEDRONIC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 71. MEDRONIC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 72. MEDRONIC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 73. ABBOTT: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 74. ABBOTT: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 75. ABBOTT: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now
RELATED TAGS

Purchase Full Report of
Cardiac Arrhythmia Monitoring Devices Market

Start reading.
This Report and over 67,404+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers